
|Poll|December 17, 2022
Poll results: Do you believe biosimilars have the same efficacy as branded medications?
Author(s)Sheryl Stevenson
Results from our recent poll indicate a mixed bag of responses from ophthalmologists.
Advertisement
Ophthalmology Times® polled our audience with the following question from December 3, 2022 to December 16, 2022:
The poll appeared on
58 responses were recorded, in total. Of these:
43% responded, "Yes."
28% responded, "No."
29% responded, "Unsure."
.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
2
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
3
Glaucoma innovation: Eight themes to watch in 2026
4
Ocugen publishes phase 1 GARDian1 gene therapy data for Stargardt disease
5












































